Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation.
Uchida M, Ushio S, Niimura T, Takechi K, Kawazoe H, Hidaka N, Tanaka A, Araki H, Zamami Y, Ishizawa K, Kitamura Y, Sendou T, Kawasaki H, Namba H, Shibata K, Tanaka M, Takatori S. Uchida M, et al. Among authors: ushio s. Biol Pharm Bull. 2022 Feb 1;45(2):226-234. doi: 10.1248/bpb.b21-00852. Epub 2021 Nov 20. Biol Pharm Bull. 2022. PMID: 34803077 Free article.
Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data.
Zamami Y, Niimura T, Kawashiri T, Goda M, Naito Y, Fukushima K, Ushio S, Aizawa F, Hamano H, Okada N, Yagi K, Miyata K, Takechi K, Chuma M, Koyama T, Kobayashi D, Shimazoe T, Fujino H, Izawa-Ishizawa Y, Ishizawa K. Zamami Y, et al. Among authors: ushio s. Biomed Pharmacother. 2022 Apr;148:112744. doi: 10.1016/j.biopha.2022.112744. Epub 2022 Feb 28. Biomed Pharmacother. 2022. PMID: 35240525 Free article.
Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System.
Matsumoto J, Iwata N, Watari S, Ushio S, Shiromizu S, Takeda T, Hamano H, Kajizono M, Araki M, Nasu Y, Ariyoshi N, Zamami Y. Matsumoto J, et al. Among authors: ushio s. Eur Urol Focus. 2023 Jan;9(1):141-144. doi: 10.1016/j.euf.2022.07.003. Epub 2022 Jul 29. Eur Urol Focus. 2023. PMID: 35915038
145 results